Insight
Life and Health Insurance M&A
We review the M&A worldwide for life and health insurers in 2021, and an outlook for 2022 and beyond.
Chronic Kidney Disease (CKD) affects many lives and has a large impact on health systems around the world. To better understand and predict costs for insurance plan members with CKD in the United States, we built a new model of their individual costs. Our model is the first to explicitly model both the CKD stage transition process and the distribution of costs given those stages.
Read the full article here.
This article was originally posted by the Society of Actuaries.
Insight
We review the M&A worldwide for life and health insurers in 2021, and an outlook for 2022 and beyond.
We’re here to help you break through complex challenges and achieve next-level success.